Literature DB >> 8500743

Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans.

I Bjarnason1, J Hayllar, A J MacPherson, A S Russell.   

Abstract

BACKGROUND: It is not widely appreciated that nonsteroidal anti-inflammatory drugs (NSAIDs) may cause damage distal to the duodenum. We reviewed the adverse effects of NSAIDs on the large and small intestine, the clinical implications and pathogenesis.
METHODS: A systematic search was made through Medline and Embase to identify possible adverse effects of NSAIDs on the large and small intestine.
RESULTS: Ingested NSAIDs may cause a nonspecific colitis (in particular, fenemates), and many patients with collagenous colitis are taking NSAIDs. Large intestinal ulcers, bleeding, and perforation are occasionally due to NSAIDs. NSAIDs may cause relapse of classic inflammatory bowel disease and contribute to serious complications of diverticular disease (fistula and perforation). NSAIDs may occasionally cause small intestinal perforation, ulcers, and strictures requiring surgery. NSAIDs, however, frequently cause small intestinal inflammation, and the associated complications of blood loss and protein loss may lead to difficult management problems. The pathogenesis of NSAID enteropathy is a multistage process involving specific biochemical and subcellular organelle damage followed by a relatively nonspecific tissue reaction. The various possible treatments of NSAID-induced enteropathy (sulphasalazine, misoprostol, metronidazole) have yet to undergo rigorous trials.
CONCLUSIONS: The adverse effects of NSAIDs distal to the duodenum represent a range of pathologies that may be asymptomatic, but some are life threatening.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8500743     DOI: 10.1016/0016-5085(93)90667-2

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  230 in total

1.  Prostaglandins and the induction of food sensitive enteropathy.

Authors:  A M Mowat
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

Review 2.  COX-2 inhibitors and the gastrointestinal tract.

Authors:  I Bjarnason; K D Rainsford
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

Review 3.  Nongranulomatous chronic idiopathic enterocolitis: a primary histologically defined disease.

Authors:  K H Soergel
Journal:  Dig Dis Sci       Date:  2000-11       Impact factor: 3.199

4.  Management of difficult inflammatory bowel disease: where are we now?

Authors:  DS Rampton
Journal:  World J Gastroenterol       Date:  2000-06       Impact factor: 5.742

Review 5.  Are cyclooxygenase 2 inhibitors free of gastrointestinal side effects?

Authors:  I Bjarnason; K D Rainsford
Journal:  West J Med       Date:  2001-10

6.  Non-steroidal anti-inflammatory drugs and perforated diverticular disease: a case-control study.

Authors:  H Goh; R Bourne
Journal:  Ann R Coll Surg Engl       Date:  2002-03       Impact factor: 1.891

7.  Rebamipide has the potential to reduce the intensity of NSAID-induced small intestinal injury: a double-blind, randomized, controlled trial evaluated by capsule endoscopy.

Authors:  Shunji Fujimori; Yoko Takahashi; Katya Gudis; Tsuguhiko Seo; Akihito Ehara; Tsuyoshi Kobayashi; Keigo Mitsui; Masaoki Yonezawa; Shu Tanaka; Atsushi Tatsuguchi; Choitsu Sakamoto
Journal:  J Gastroenterol       Date:  2010-10-06       Impact factor: 7.527

8.  Prostaglandin E2 is the major arachidonic acid metabolite secreted by esophageal mucosal cells in rabbits.

Authors:  P Jiménez; A Lanas; E Piazuelo; G Bioque; F Esteva
Journal:  Inflammation       Date:  1997-08       Impact factor: 4.092

9.  Antiinflammatory drug-induced small intestinal permeability: the rat is a suitable model.

Authors:  N M Davies; M R Wright; F Jamali
Journal:  Pharm Res       Date:  1994-11       Impact factor: 4.200

10.  Inhibitory effect of fluvastatin on ileal ulcer formation in rats induced by nonsteroidal antiinflammatory drug.

Authors:  Mari Hagiwara; Keiko Kataoka; Hideki Arimochi; Tomomi Kuwahara; Haruyuki Nakayama; Yoshinari Ohnishi
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.